Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review
Keywords: 
COVID
Cross-reactivity
Immunorelated
Morphea
Vaccination
Issue Date: 
2022
Publisher: 
Wiley
ISSN: 
1529-8019
Note: 
This is an open access article under the terms of the Creative Commons Attribution License
Citation: 
Antoñanzas, J. (Javier); Rodríguez-Garijo, N. (Nuria); Estenaga, Á. (Ángela); et al. "Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review". Dermatologic Therapy. 35, 2022, e15709
Abstract
The appearance of morphea after vaccination has been reported to date as single and deep lesions that appear exactly at the site of the skin puncture. It was therefore postulated that the origin could be the trauma related to the injection. The aim of this article is to review the various hypotheses offered in the published literature about generalized morphea following vaccination. We present two cases of generalized morphea after COVID-19 vaccination and review the published literature on immune-related cutaneous reactions. As previously reported, antigenic crossreactivity between vaccine spike proteins and human tissues could cause certain immune-mediated diseases, including generalized morphea. Herein we report two cases of generalized morphea probably induced by the COVID-19 vaccine, given the temporal relationship with its administration. In summary, environmental factors such as vaccination against SARS-COV-2 could induce an immune system dysregulation, which would have an important role in the pathogenesis of morphea. We present two cases of generalized morphea probably induced by the COVID-19 vaccine, given the time elapsed between vaccination and the onset of the skin lesions.

Files in This Item:
Thumbnail
File
Generalized_morphea_following_the_COVID_vaccine_A_.pdf
Description
Size
1.1 MB
Format
Adobe PDF


Statistics and impact

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.